Spoken Alpha
INTUITIVE SURGICAL INC
Intuitive Surgical designs and manufactures robotic-assisted surgical systems, including the da Vinci surgical platform for minimally invasive procedures across general, urologic, gynecologic, cardiothoracic, and head and neck specialties, and the Ion endoluminal system for lung biopsies.
INTUITIVE SURGICAL INC is a Healthcare company operating in Medical Instruments & Supplies with a $132.26B market cap.
Most recent reported earnings: Q3 FY2026 (Oct 19, 2026).
22 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from SEC 10-K filing, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ISRG.
$ curl https://api.spokenalpha.com/v1/companies/ISRGFAQ
Spoken Alpha indexes ISRG's earnings call transcripts at https://spokenalpha.com/companies/ISRG. Each call links to attributed speakers and parsed analyst Q&A. INTUITIVE SURGICAL INC's own investor relations page is at https://investor.intuitivesurgical.com/.
INTUITIVE SURGICAL INC (ISRG) held its most recent earnings call on 2026-07-16, covering fiscal Q2 2026.
INTUITIVE SURGICAL INC (ISRG) operates in the Healthcare sector (Medical Instruments & Supplies industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-19 | — | $2.13 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-07-15 | $2.80 | $2.02 | +38.6% | $2.89B | — | — | EODHDDisagrees |
| Q1 FY2026 | 2026-04-20 | $2.50 | $2.11 | +18.5% | $2.77B | — | — | EODHD |
| Q4 FY2025 | 2026-01-21 | $2.53 | $2.27 | +11.5% | $2.87B | — | — | EODHD |
| Q3 FY2025 | 2025-10-20 | $2.40 | $1.99 | +20.6% | $2.51B | — | — | EODHD |
| Q2 FY2025 | 2025-07-21 | $2.19 | $1.92 | +14.1% | $2.44B | — | — | EODHD |
| Q1 FY2025 | 2025-04-21 | $1.81 | $1.73 | +4.6% | $2.25B | — | — | EODHD |
| Q4 FY2024 | 2025-01-22 | $2.21 | $1.79 | +23.5% | $2.41B | — | — | EODHD |
| Q3 FY2024 | 2024-10-16 | $1.84 | $1.64 | +12.2% | $2.04B | — | — | EODHD |
| Q2 FY2024 | 2024-07-17 | $1.78 | $1.54 | +15.6% | $2.01B | — | — | EODHD |
| Q1 FY2024 | 2024-04-17 | $1.50 | $1.42 | +5.6% | $1.89B | — | — | EODHD |
| Q4 FY2023 | 2024-01-22 | $1.60 | $1.49 | +7.4% | $1.93B | — | — | EODHD |
| Q3 FY2023 | 2023-10-18 | $1.46 | $1.42 | +2.8% | $1.74B | — | — | EODHD |
| Q2 FY2023 | 2023-07-19 | $1.42 | $1.33 | +6.8% | $1.76B | — | — | EODHD |
| Q1 FY2023 | 2023-04-17 | $1.23 | $1.20 | +2.5% | $1.70B | — | — | EODHD |
| Q4 FY2022 | 2023-01-23 | $1.23 | $1.25 | -1.6% | $1.66B | — | — | EODHD |
| Q3 FY2022 | 2022-10-17 | $1.19 | $1.12 | +6.3% | $1.56B | — | — | EODHD |
| Q2 FY2022 | 2022-07-20 | $1.14 | $1.20 | -5.0% | $1.52B | — | — | EODHD |
| Q1 FY2022 | 2022-04-20 | $1.13 | $1.08 | +4.6% | $1.49B | — | — | EODHD |
| Q4 FY2021 | 2022-01-19 | $1.30 | $1.28 | +1.6% | $1.55B | — | — | EODHD |
Source: EODHD. Some rows have cross-provider disagreement flags (see badge). ISRG reported actuals as published; sparse fields render as —.